Factor VII deficiency and cardiac surgery

2004 ◽  
Vol 21 (Supplement 32) ◽  
pp. 84-85
Author(s):  
T. Tuna ◽  
J. Massaut ◽  
P. Wauthy ◽  
S. Beckers
Keyword(s):  
Cardiac Surgery ◽  
Factor Vii ◽  
Factor Vii Deficiency

Cardiac Surgery with Extracorporeal Circulation in Severe Factor VII Deficiency

1993 ◽  
Vol 23 (1) ◽  
pp. 65-68 ◽  
Author(s):  
A. Ferster ◽  
V. Capouet ◽  
A. Deville ◽  
P. Fondu ◽  
F. Corazza
Keyword(s):  
Cardiac Surgery ◽  
Extracorporeal Circulation ◽  
Factor Vii ◽  
Factor Vii Deficiency

Cardiac Surgery Without Blood Products in a Jehovah's Witness Child With Factor VII Deficiency

2012 ◽  
Vol 26 (4) ◽  
pp. 651-653 ◽  
Author(s):  
Antonio Pérez-Ferrer ◽  
Elena Gredilla ◽  
Jesús de Vicente ◽  
Yolanda Laporta
Keyword(s):  
Cardiac Surgery ◽  
Factor Vii ◽  
Blood Products ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Factor Vii Deficiency

Factor VII deficiency: do all need replacement for cardiac surgery?

2017 ◽  
Vol 27 (1) ◽  
pp. 42-44
Author(s):  
Fayaz Mohammed Khazi ◽  
Nayyer R Siddiqi ◽  
Yehia M Karaly ◽  
Bassil Al-Zamkan ◽  
Faouzi DIT Safadi ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Coronary Artery Bypass Surgery ◽  
Bypass Surgery ◽  
Recombinant Factor Viia ◽  
Factor Viia ◽  
Artery Bypass ◽  
International Normalized Ratio ◽  
Factor Vii ◽  
Coronary Anatomy ◽  
Factor Vii Deficiency

In cardiac surgery, supplementation with recombinant factor VIIa is the treatment of choice for patients with factor VII deficiency, but overzealous administration can be associated with thromboembolic side-effects. A 53-year-old man with factor VII activity 15.2%, international normalized ratio 2.9, and acute thrombotic critical coronary anatomy, underwent coronary artery bypass surgery and a thoracotomy with decortication 5 months later. He was managed successfully without recombinant factor VIIa supplementation. This case demonstrates that current bedside and laboratory tests such as thromboelastography, prothrombin time or international normalized ratio, and factor VII activity may not predict replacement therapy in these patients.

Inherited Factor VII Deficiency: Genetics and Molecular Pathology

1995 ◽  
Vol 74 (01) ◽  
pp. 313-321 ◽  
Author(s):  
Edward G D Tuddenham ◽  
Susan Pemberton ◽  
David N Cooper
Keyword(s):  
Molecular Pathology ◽  
Factor Vii ◽  
Factor Vii Deficiency

Two Typical Hereditary Charts of Congenital Factor VII Deficiency

1961 ◽  
Vol 05 (01) ◽  
pp. 087-092 ◽  
Author(s):  
F. J Cleton ◽  
E. A Loeliger
Keyword(s):  
Factor Vii ◽  
Autosomal Gene ◽  
Homozygous State ◽  
Recessive Character ◽  
Factor Vii Deficiency ◽  
Complete Penetrance ◽  
Coagulation Defect ◽  
Haemorrhagic Diathesis ◽  
Intermediate Expression ◽  
Congenital Factor

SummaryThe inheritance of congenital factor VII deficiency was investigated in 2 unrelated families. Out of 68 individuals, 4 (3 proven and 1 highly probable) were found to have severe factor VII deficiency (<C 0.1% factor VII), and 29 appeared to be heterozygotes (30—60% factor VII). The coagulation defect is due to an autosomal gene of intermediate expression and complete penetrance. The recessive character of the haemorrhagic diathesis due to the homozygous state for the abnormal gene is clearly demonstrated.

Paracetamol poisoning unmasking factor VII deficiency

2002 ◽  
Vol 14 (4) ◽  
pp. 441-443 ◽  
Author(s):  
Andrew P. Chilton ◽  
Tariq Hussain ◽  
Elwyn Elias
Keyword(s):  
Factor Vii ◽  
Paracetamol Poisoning ◽  
Factor Vii Deficiency
Sign in / Sign up

Export Citation Format

Share Document